# Blend Labs, Inc.: overview BLND · NYSE · CIK 1855747 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/blnd.md) · [Financials](/companies/blnd/financials.md) · [Filings](/companies/blnd/filings.md) · [Insiders](/companies/blnd/insiders.md) Latest reported revenue: [$33.8m](/filings/0001855747-26-000057.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001855747-26-000057). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [33.1](/filings/0001855747-25-000092.md) | [30.1 d](/filings/0001855747-26-000016.md) | [26.8](/filings/0001855747-26-000042.md) | [31.6](/filings/0001855747-26-000057.md) | [32.7](/filings/0001855747-26-000016.md) | [31.6](/filings/0001855747-26-000057.md) | [30.8](/filings/0001855747-26-000042.md) | [33.8](/filings/0001855747-26-000057.md) | | Gross margin | % | [74.0%](/filings/0001855747-25-000092.md) | [74.2% d](/filings/0001855747-26-000016.md) | [70.8%](/filings/0001855747-26-000042.md) | [73.8%](/filings/0001855747-26-000057.md) | [74.3%](/filings/0001855747-26-000016.md) | [73.8%](/filings/0001855747-26-000057.md) | [75.8%](/filings/0001855747-26-000042.md) | [73.5%](/filings/0001855747-26-000057.md) | | Operating margin | % | [(34.1%)](/filings/0001855747-25-000092.md) | [(10.9%) d](/filings/0001855747-26-000016.md) | [(29.7%)](/filings/0001855747-26-000042.md) | [(15.3%)](/filings/0001855747-26-000057.md) | [(16.4%)](/filings/0001855747-26-000016.md) | [(15.3%)](/filings/0001855747-26-000057.md) | [(16.4%)](/filings/0001855747-26-000042.md) | [(4.7%)](/filings/0001855747-26-000057.md) | | Net margin | % | [(7.4%)](/filings/0001855747-25-000092.md) | [(2.7%) d](/filings/0001855747-26-000016.md) | [(35.5%)](/filings/0001855747-26-000057.md) | [(21.6%)](/filings/0001855747-26-000057.md) | [37.0%](/filings/0001855747-26-000016.md) | [(21.6%)](/filings/0001855747-26-000057.md) | [(26.1%)](/filings/0001855747-26-000057.md) | [(4.4%)](/filings/0001855747-26-000057.md) | | Diluted EPS | $ per share | [(0.03)](/filings/0001855747-25-000092.md) | not reported | [(0.06)](/filings/0001855747-26-000042.md) | [(0.04)](/filings/0001855747-26-000057.md) | [0.02](/filings/0001855747-26-000016.md) | not reported | [(0.05)](/filings/0001855747-26-000042.md) | [(0.03)](/filings/0001855747-26-000057.md) | | Free cash flow | $m | [(1.4) d](/filings/0001855747-25-000092.md) | [(7.1) d](/filings/0001855747-26-000016.md) | [15.8](/filings/0001855747-26-000042.md) | [(10.1) d](/filings/0001855747-26-000057.md) | [(5.8) d](/filings/0001855747-26-000016.md) | [(0.0) d](/filings/0001855747-26-000016.md) | [6.2](/filings/0001855747-26-000042.md) | [7.1 d](/filings/0001855747-26-000057.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [234](/filings/0001855747-24-000015.md) | [235](/filings/0001855747-25-000017.md) | [110](/filings/0001855747-26-000016.md) | [116](/filings/0001855747-26-000016.md) | [124](/filings/0001855747-26-000016.md) | | Gross margin | % | [49.5%](/filings/0001855747-24-000015.md) | [38.1%](/filings/0001855747-25-000017.md) | [69.8%](/filings/0001855747-26-000016.md) | [71.9%](/filings/0001855747-26-000016.md) | [73.8%](/filings/0001855747-26-000016.md) | | Operating margin | % | [(84.1%)](/filings/0001855747-24-000015.md) | [(317.3%)](/filings/0001855747-25-000017.md) | [(131.1%)](/filings/0001855747-26-000016.md) | [(42.2%)](/filings/0001855747-26-000016.md) | [(17.6%)](/filings/0001855747-26-000016.md) | | Net margin | % | [(72.5%)](/filings/0001855747-24-000015.md) | [(306.2%)](/filings/0001855747-25-000017.md) | [(163.1%)](/filings/0001855747-26-000016.md) | [(37.4%)](/filings/0001855747-26-000016.md) | [(5.5%)](/filings/0001855747-26-000016.md) | | Diluted EPS | $ per share | [(1.30)](/filings/0001855747-24-000015.md) | [(3.28)](/filings/0001855747-25-000017.md) | [(0.76)](/filings/0001855747-26-000016.md) | [(0.24)](/filings/0001855747-26-000016.md) | [(0.10)](/filings/0001855747-26-000016.md) | | Free cash flow | $m | [(129)](/filings/0001855747-24-000015.md) | [(192)](/filings/0001855747-25-000017.md) | [(128)](/filings/0001855747-26-000016.md) | [(22.8)](/filings/0001855747-26-000016.md) | [(0.1)](/filings/0001855747-26-000016.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/blnd/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Haveli Investment Management LLC](/funds/2022286.md) | 2026-06-30 | $32.0m | 18,693,667 | | Added +7,844,794 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $26.6m | 15,579,341 | | Reduced −707,844 | | [CYPRESS POINT INVESTMENT MANAGEMENT LP](/funds/2058475.md) | 2026-06-30 | $24.4m | 14,297,425 | | Reduced −239,747 | | [Capricorn Fund Managers Ltd](/funds/1901361.md) | 2026-06-30 | $19.3m | 11,314,649 | | Added +4,815,142 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.5m | 8,486,286 | | Reduced −1,166,160 | | [Whitebark Investors LP](/funds/2042091.md) | 2026-06-30 | $10.8m | 6,343,497 | | Unchanged | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $10.6m | 6,216,044 | | Reduced −486,903 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $10.6m | 6,174,857 | | Reduced −123,453 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.7m | 5,080,868 | | Added +240,478 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $8.7m | 5,062,868 | | Added +370,351 | ## Recent filings [All 550 filings](/companies/blnd/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-21 | 16:12 ET | [8-K](/filings/0001855747-26-000064.md) | 5.02 Departure or appointment of officers or directors | 0001855747-26-000064 | | 2026-08-11 | 16:23 ET | [8-K](/filings/0001855747-26-000060.md) | 5.02 Departure or appointment of officers or directors | 0001855747-26-000060 | | 2026-08-06 | 16:09 ET | [10-Q](/filings/0001855747-26-000057.md) | Quarterly report, period 2026-06-30 | 0001855747-26-000057 | | 2026-08-06 | 16:07 ET | [8-K](/filings/0001855747-26-000056.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001855747-26-000056 | | 2026-06-23 | 21:29 ET | [8-K](/filings/0001855747-26-000045.md) | 5.07 Shareholder vote results | 0001855747-26-000045 | | 2026-06-12 | 21:51 ET | [SCHEDULE 13D/A](/filings/0001193125-26-270049.md) | Ownership report, active investor, amended | 0001193125-26-270049 | | 2026-05-15 | 21:05 ET | [SCHEDULE 13D/A](/filings/0001193125-26-227569.md) | Ownership report, active investor, amended | 0001193125-26-227569 | | 2026-05-07 | 16:04 ET | [10-Q](/filings/0001855747-26-000042.md) | Quarterly report, period 2026-03-31 | 0001855747-26-000042 | | 2026-05-07 | 16:00 ET | [8-K](/filings/0001855747-26-000040.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001855747-26-000040 | | 2026-04-29 | 16:08 ET | [DEF 14A](/filings/0001855747-26-000023.md) | Proxy statement, period 2026-04-24 | 0001855747-26-000023 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001855747-26-000016.md), filed Mar 16, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f20eb5af-5828-46dd-b2f9-dfe32514b19a) ## About the filer - CIK: 1855747 - Tickers: BLND - Exchange: NYSE - SIC code: 7370 Services-Computer Programming, Data Processing, Etc. - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:28 ET. No prices; not investment advice.